THE IMPACT OF FAMILY HISTORY ON OVARIAN-CANCER RISK - THE UTAH POPULATION DATABASE

被引:43
作者
KERBER, RA
SLATTERY, ML
机构
关键词
D O I
10.1001/archinte.155.9.905
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To estimate the relative risks and population attributable risks of ovarian cancer associated with family histories of cancer at several sites. Methods: A matched case-control analytic study (662 cases, 2647 controls), employing the Utah Population Database, a genealogy of approximately 1 million individuals linked to cancer incidence data from the Utah Cancer Registry. Family history was assessed using kinship order and a kinship-weighted familial standardized incidence ratio statistic. Results: Family histories of ovarian, uterine, breast, and pancreatic cancer were significantly associated with increased risk of ovarian cancer. The relative risk of ovarian cancer was 4.31 (95% confidence interval [CI], 2.35 to 7.90) for women with a first-degree: relative with ovarian cancer, 2.12 (95% CI, 1.19 to 3.78) for women with an affected second-degree relative, and 1.48 (95% CI, 0.98 to 2.24) for women with an affected third-degree relative. The odds ratio (OR) was 2.06 (95% CI, 1.44 to 2.93) for those with the highest familial standardized incidence ratio. No age differences were observed between cases with and without a family history of ovarian cancer. There was substantial heterogeneity of family history effects by cell type. Increased parity was not protective among women with a strong family history of cancer at the sites studied (OR, 1.11; 95% CI, 0.38 to 3.26), although it was protective among women without a family history of these cancers (OR, 0.29; 95% CI, 0.11 to 0.62). Conclusions: The risk of ovarian cancer was substantially increased among women with family histories of ovarian, uterine, pancreatic, and, to a lesser degree, breast cancer. Among women with family histories of any of these cancers, the risk of ovarian cancer is not diminished by high parity.
引用
收藏
页码:905 / 912
页数:8
相关论文
共 57 条
[31]  
LYNCH HT, 1993, CANCER-AM CANCER SOC, V71, P573
[32]  
Malecot G., 1948, MATH HEREDITE
[33]   GERM LINE P53 MUTATIONS IN A FAMILIAL SYNDROME OF BREAST-CANCER, SARCOMAS, AND OTHER NEOPLASMS [J].
MALKIN, D ;
LI, FP ;
STRONG, LC ;
FRAUMENI, JF ;
NELSON, CE ;
KIM, DH ;
KASSEL, J ;
GRYKA, MA ;
BISCHOFF, FZ ;
TAINSKY, MA ;
FRIEND, SH .
SCIENCE, 1990, 250 (4985) :1233-1238
[34]  
MCGOWAN L, 1988, European Journal of Gynaecological Oncology, V9, P195
[35]   EPITHELIAL OVARIAN-CANCER AND COFFEE-DRINKING [J].
MILLER, DR ;
ROSENBERG, L ;
KAUFMAN, DW ;
HELMRICH, SP ;
SCHOTTENFELD, D ;
LEWIS, J ;
STOLLEY, PD ;
ROSENSHEIN, N ;
SHAPIRO, S .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1987, 16 (01) :13-17
[36]   REPRODUCTIVE, GENETIC, AND DIETARY RISK-FACTORS FOR OVARIAN-CANCER [J].
MORI, M ;
HARABUCHI, I ;
MIYAKE, H ;
CASAGRANDE, JT ;
HENDERSON, BE ;
ROSS, RK .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1988, 128 (04) :771-777
[37]   HISTOLOGY OF BRCA1-ASSOCIATED OVARIAN-TUMORS [J].
NAROD, S ;
TONIN, P ;
LYNCH, H ;
WATSON, P ;
FEUNTEUN, J ;
LENOIR, G .
LANCET, 1994, 343 (8891) :236-236
[38]   FAMILY HISTORY OF REPRODUCTIVE CANCERS AND OVARIAN-CANCER RISK - AN ITALIAN CASE-CONTROL STUDY [J].
PARAZZINI, F ;
NEGRI, E ;
LAVECCHIA, C ;
RESTELLI, C ;
FRANCESCHI, S .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 135 (01) :35-40
[39]  
PELTOMAKI P, 1993, CANCER RES, V53, P5853
[40]  
PIVER MS, 1993, CANCER-AM CANCER SOC, V71, P582